Skip to main content

New England Biolabs to Distribute Rubicon Amplification Tech in Kit

NEW YORK (GenomeWeb News) – New England Biolabs will distribute Rubicon Genomics' amplification technology as part of a kit being sold for single-cell amplification, the firms announced today.

Ipswich, Mass.-based New England Biolabs will offer the Single Cell Whole Genome Amplification Kit, which will include the Rubicon technology that enables the amplification of DNA from single cells or extremely low amounts of input DNA. New England Biolabs said that the kit is its first product aimed at the single-cell amplification market.

"This single cell amplification technology has already been widely adopted in the in vitro fertilization (IVF) market, and we are excited at the prospects this product has in research applications," Jim Koziarz, president and CEO of Rubicon, said in a statement.

Terms of the agreement were not disclosed.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.